7AE-20582-12953
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 370 / TN
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-01-30
Registered in v-safe
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-14
- 2021-04-30
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: TinnitusMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-30
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-11
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Brain fog, Fatigue, Gastritis, Neuropathy peripheral, Oesophagitis, Tinnitus, Vertigo positional — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Brain fog, fatigue, ongoing tinnitus, benign positional vertigo, esophagitis, gastritis and neuropathy in my legs and feetMedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-01
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-30 | Unsuccessful | |
| 2022-01-29 | Successful 2022-02-01 |
Participant prefers to complete VAERS report online |
Free text
Release 9 — 6 months, dose 2
Symptoms: Tinnitus
Release 11 — 12 months, dose 2
Symptoms: Brain fog, fatigue, ongoing tinnitus, benign positional vertigo, esophagitis, gastritis and neuropathy in my legs and feet
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastritis | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Oesophagitis | · | · | ✓ |
| SD | Tinnitus | ✓ | · | ✓ |
| SD | Vertigo positional | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release